Sergio Carmona

researcher (ORCID 0000-0002-6792-4748)

Sergio Carmona is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID0671406106.09
P496ORCID iD0000-0002-6792-4748
P1153Scopus author ID6701762464

P108employerUniversity of the Witwatersrand Faculty of Health SciencesQ5428977
FIND, the global alliance for diagnosticsQ5474445
National Health Laboratory ServiceQ17052573
P734family nameCarmonaQ16865386
CarmonaQ16865386
CarmonaQ16865386
P735given nameSergioQ18061657
SergioQ18061657
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q42234063A serious parvovirus B19 genotype 2 infection not detected in a commercial PCR assay
Q46329054Absence of Acanthocytosis in Huntington's Disease-like 2: A Prospective Comparison with Huntington's Disease
Q52641448Adult antiretroviral therapy guidelines 2017.
Q93355465Appropriate clinical use of darunavir 800 mg
Q51736507Collaborative care for the detection and management of depression among adults receiving antiretroviral therapy in South Africa: study protocol for the CobALT randomised controlled trial.
Q40104085Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation
Q35331479Design and implementation of an external quality assessment program for HIV viral load measurements using dried blood spots
Q38852072Early Diagnosis of HIV Infection in Infants - One Caribbean and Six Sub-Saharan African Countries, 2011-2015.
Q46278917Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
Q55205473Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa.
Q36033368Exploiting the RNA interference pathway to counter hepatitis B virus replication.
Q40064365Field Evaluation of Performance of Alere and Cepheid Qualitative HIV Assays for Pediatric Point-of-Care Testing in an Academic Hospital in Soweto, South Africa
Q41919022HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis
Q39109215HIV viral load scale-up: multiple interventions to meet the HIV treatment cascade.
Q28271593HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing
Q39360243HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.
Q28543358High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa
Q28538692High-level cross-resistance to didanosine observed in South African children failing an abacavir- or stavudine-based 1st-line regimen
Q37040586Improved Sensitivity of a Dual-Target HIV-1 Qualitative Test for Plasma and Dried Blood Spots
Q56948059Improving Linkage to HIV Care Through Mobile Phone Apps: Randomized Controlled Trial
Q64085811Improving Linkage to and Retention in Care in Newly Diagnosed HIV-Positive Patients Using Smartphones in South Africa: Randomized Controlled Trial
Q31155083Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study
Q35455196Laboratory evaluation of the Liat HIV Quant (IQuum) whole-blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa
Q34409299Lower frequency of NPM1 and FLT3-ITD mutations in a South African adult de novo AML cohort
Q38380464Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa
Q28554729Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey
Q33603586Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration
Q42576460Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan version 2.0 human immunodeficiency virus type 1 assay.
Q52669148Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort.
Q39125858Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa.
Q38851986Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.
Q53763317Recommendations for the management of indeterminate HIV PCR results within South Africa's early infant diagnosis programme.
Q38371483Scale-up of Early Infant HIV Diagnosis and Improving Access to Pediatric HIV Care in Global Plan Countries: Past and Future Perspectives
Q39165543Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries
Q91386119Separation of Plasma from Whole Blood by Use of the cobas Plasma Separation Card: a Compelling Alternative to Dried Blood Spots for Quantification of HIV-1 Viral Load
Q40278977Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag.
Q44727822Simplified ELISA for detecting antibodies to recombinant fusion proteins.
Q52641450South African HIV self-testing policy and guidance considerations.
Q93355458Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
Q39044352The cobas® 6800/8800 System: a new era of automation in molecular diagnostics
Q36414140Use of a prequalification panel for rapid scale-up of high-throughput HIV viral load testing.
Q37610648Viral tropism and antiretroviral drug resistance in HIV-1 subtype C-infected patients failing highly active antiretroviral therapy in Johannesburg, South Africa
Q89876272Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study

Search more.